“…The exact role of FcγRs in disease manifestation is unclear but it has been suggested that harboring a certain FcγR phenotype could be risk factor in development of specific diseases [139]. For example, the FcγRIIa-H131 genotype was found to be associated with an increased production of the pro-inflammatory cytokine IL-1β by mononuclear cells, leading to inter-individual differences in the risk for acquiring periodontitis [140]. In multiple studies carried out in diverse ethnic populations, significant associations were found between FcγR polymorphisms and inter-individual differences in susceptibility, prevalence, and prognosis of diseases like systemic lupus erythematosus (SLE) [141][142][143][144], rheumatoid arthritis (RA) [145,146], immune thrombocytopenia [147], Guillain-Barré syndrome [148][149][150], myasthenia gravis [151] pediatric autoimmune neutropenia [152], IgA nephropathy [153], inflammatory myopathies [154], anti-glomerular basement membrane antibody disease [155], Kawasaki Disease [156], periodontitis [157,158], malaria [159,160], dengue [161], and sickle cell disease [162].…”